Danaher Corporation
Financials
Valuation Metrics
Danaher Corporation's Market Cap is $164.39B. At end of 2025 it was $162.05B. Ranked #92 of 3,116 in US market (top 3%), #58 of 1,644 on NYSE (top 4%), #4 of 203 in Health Care Equipment & Services (top 2%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $164.39B | US#92/3,116 Sec#4/203 |
| Revenue | $25.61B | US#253/3,116 Sec#17/203 |
| Net Income | $4.33B | US#181/3,116 Sec#10/203 |
| Total Assets | $93.28B | US#188/3,116 Sec#8/203 |
| Net Assets | $53.62B | US#80/3,116 Sec#3/203 |
| Employees | 58,000 | US#224/3,116 Sec#20/203 |
| Value | ||
| P/E | 37.96x | US#1,760/3,116 Sec#79/203 |
| P/B | 3.07x | US#1,808/3,116 Sec#95/203 |
| PEG | 1.61x | US#971/3,116 Sec#46/203 |
| P/S | 6.42x | US#2,482/3,116 Sec#161/203 |
| EV/EBITDA | 26.13x | US#2,130/3,116 Sec#104/203 |
| FCF Yield | 3.48% | US#1,713/3,116 Sec#94/203 |
| Profitability | ||
| ROE | 8.08% | US#1,576/3,116 Sec#78/203 |
| ROA | 4.64% | US#1,107/3,116 Sec#71/203 |
| Op. Margin | 20.38% | US#869/3,116 Sec#29/203 |
| Revenue Growth | 5.52% | US#1,711/3,116 Sec#124/203 |
| Earnings Growth | 23.64% | US#788/3,116 Sec#42/203 |
| Financial Health | ||
| Debt Ratio | 73.96% | US#813/3,116 Sec#83/203 |
| Total Debt | $26.48B | US#179/3,116 Sec#9/203 |
| FCF | $5.73B | US#145/3,116 Sec#10/203 |
| Cash | $5.68B | US#181/3,116 Sec#8/203 |
| Current Ratio | 1.63x | US#1,514/3,116 Sec#136/203 |
| Net Debt/EBITDA | 2.94x | US#1,588/3,116 Sec#98/203 |
| Dividend | ||
| Div. Yield | 0.62% | US#1,477/3,116 Sec#37/203 |
| Div. Growth | 18.15% | US#278/3,116 Sec#8/203 |
| Performance | ||
| 1Y Return | 8.15% | US#1,466/3,116 Sec#111/203 |
| 1M Return | 4.83% | US#1,301/3,116 Sec#126/203 |
| From 52W High | -4.34% | US#249/3,116 Sec#32/203 |
| 1Y MDD | -33.11% | US#1,524/3,116 Sec#88/203 |
| Trading | ||
| Volume | 2,894,623 shares | US#844/3,116 Sec#42/203 |
| Trading Value | $676M | US#215/3,116 Sec#14/203 |
| Per Share | ||
| EPS | $6.12 | US#545/3,116 Sec#33/203 |
| BPS | $75.76 | US#193/3,116 Sec#15/203 |
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.